TP53-positive clones are responsible for drug-tolerant persister and recurrence of HER2-positive breast cancer.
Hideki WatanabeHiroshi NakagomiYosuke HirotsuKenji AmemiyaHitoshi MochizukiMasayuki InoueAyako KimuraMasao OmataPublished in: Breast cancer research and treatment (2022)
Not applicable.